CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 80 enrolled
Drug / intervention
Ropivacaine - Tramadol +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02182752
NCT02182752Phase 2Completed

The Effect of Tramadol on Interscalene Brachial Plexus Block With Ropivacaine in Shoulder Surgery.

Asklepieion Voulas General Hospital·interventional·Posted Jul 8, 2014·Updated Jan 5, 2016

In Brief

A Phase 2 clinical trial evaluating Ropivacaine - Tramadol and Ropivacaine for Shoulder Fracture and 3 related conditions. Completed, enrolled 80 participants across 1 site.

Detailed Summary

The purpose of our study is to evaluate the effect of tramadol as an adjunct to ropivacaine local anesthetic solution in interscalene brachial plexus block for shoulder surgery.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesGreece

Timeline

Phase 2CompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedJul 8, 2014
Enrollment StartApr 1, 2013
Primary CompletionJan 1, 2016
TodayJul 2, 2026
Enrollment to primary: 2.8 yearsPosted 12.0 years ago

Interventions

Ropivacaine - Tramadoldrug

Interscalene block using ropivacaine plus tramadol

Ropivacainedrug

Interscalene block using ropivacaine